BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17575270)

  • 1. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.
    Nikolsky E; Mehran R; Dangas G; Fahy M; Na Y; Pocock SJ; Lincoff AM; Stone GW
    Eur Heart J; 2007 Aug; 28(16):1936-45. PubMed ID: 17575270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.
    Fuchs S; Kornowski R; Teplitsky I; Brosh D; Lev E; Vaknin-Assa H; Ben-Dor I; Iakobishvili Z; Rechavia E; Battler A; Assali A
    Cardiovasc Revasc Med; 2009; 10(2):88-93. PubMed ID: 19327670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk Score.
    Mangiacapra F; Ricottini E; Barbato E; Demartini C; Peace A; Patti G; Vizzi V; De Bruyne B; Wijns W; Di Sciascio G
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25940521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.
    Bertrand OF; Larose E; Rodés-Cabau J; Gleeton O; Taillon I; Roy L; Poirier P; Costerousse O; Larochellière RD
    Am Heart J; 2009 Jan; 157(1):164-9. PubMed ID: 19081414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).
    Byrne J; Spence MS; Fretz E; Mildenberger R; Chase A; Berry B; Pi D; Janssen C; Klinke P; Hilton D
    Am J Cardiol; 2009 Feb; 103(4):507-11. PubMed ID: 19195511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score.
    Madan P; Elayda MA; Lee VV; Wilson JM
    Am Heart J; 2008 Jun; 155(6):1068-74. PubMed ID: 18513521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention.
    Montalescot G; Salette G; Steg G; Cohen M; White HD; Gallo R; Steinhubl SR
    Int J Cardiol; 2011 Jul; 150(1):79-83. PubMed ID: 20299114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.
    Farouque HM; Tremmel JA; Raissi Shabari F; Aggarwal M; Fearon WF; Ng MK; Rezaee M; Yeung AC; Lee DP
    J Am Coll Cardiol; 2005 Feb; 45(3):363-8. PubMed ID: 15680713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years.
    Ko DT; Yun L; Wijeysundera HC; Jackevicius CA; Rao SV; Austin PC; Marquis JF; Tu JV
    Circ Cardiovasc Interv; 2010 Apr; 3(2):140-7. PubMed ID: 20332382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.
    Bartholomew BA; Harjai KJ; Dukkipati S; Boura JA; Yerkey MW; Glazier S; Grines CL; O'Neill WW
    Am J Cardiol; 2004 Jun; 93(12):1515-9. PubMed ID: 15194023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel percutaneous coronary intervention risk score to predict one-year mortality.
    Maluenda G; Delhaye C; Gaglia MA; Ben-Dor I; Gonzalez MA; Hanna NN; Collins SD; Wakabayashi K; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2010 Sep; 106(5):641-5. PubMed ID: 20723638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the national cardiovascular data registry.
    Singh M; Peterson ED; Milford-Beland S; Rumsfeld JS; Spertus JA
    Circ Cardiovasc Interv; 2008 Aug; 1(1):36-44. PubMed ID: 20031653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious renal dysfunction after percutaneous coronary interventions can be predicted.
    Brown JR; DeVries JT; Piper WD; Robb JF; Hearne MJ; Ver Lee PM; Kellet MA; Watkins MW; Ryan TJ; Silver MT; Ross CS; MacKenzie TA; O'Connor GT; Malenka DJ;
    Am Heart J; 2008 Feb; 155(2):260-6. PubMed ID: 18215595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of vascular complications following PCI.
    Applegate R; Sacrinty M; Little W; Gandhi S; Kutcher M; Santos R
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):64-73. PubMed ID: 19202551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention.
    Kunadian B; Dunning J; Das R; Roberts AP; Morley R; Turley AJ; Twomey D; Hall JA; Wright RA; Sutton AG; Muir DF; de Belder MA
    Heart; 2008 Aug; 94(8):1012-8. PubMed ID: 18032457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention.
    Aggarwal A; Dai D; Rumsfeld JS; Klein LW; Roe MT
    Am J Cardiol; 2008 May; 101(10):1413-7. PubMed ID: 18471451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study.
    Chin MW; Yong G; Bulsara MK; Rankin J; Forbes GM
    Am J Gastroenterol; 2007 Nov; 102(11):2411-6. PubMed ID: 17850413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.
    Karjalainen PP; Vikman S; Niemelä M; Porela P; Ylitalo A; Vaittinen MA; Puurunen M; Airaksinen TJ; Nyman K; Vahlberg T; Airaksinen KE
    Eur Heart J; 2008 Apr; 29(8):1001-10. PubMed ID: 18346963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.